Lenze EJ - Search Results

1

Beyond "Psychotropic": Repurposing Psychiatric Drugs for COVID-19, Alzheimer's Disease, and Cancer.

Lenze EJ, Reiersen AM, Zorumski CF, Santosh PJ. Lenze EJ, et al. J Clin Psychiatry. 2023 Mar 20;84(3):22r14494. doi: 10.4088/JCP.22r14494. J Clin Psychiatry. 2023. PMID: 36946597 Review.

2

Washington University & the Future of Psychiatry.

Lenze EJ, Zorumski CF. Lenze EJ, et al. Mo Med. 2023 Jul-Aug;120(4):266-267. Mo Med. 2023. PMID: 37609468 Free PMC article. No abstract available.

3

Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression.

Ly M, Yu GZ, Mian A, Cramer A, Meysami S, Merrill DA, Samara A, Eisenstein SA, Hershey T, Babulal GM, Lenze EJ, Morris JC, Benzinger TLS, Raji CA. Ly M, et al. Among authors: lenze ej. Am J Geriatr Psychiatry. 2023 Oct;31(10):853-866. doi: 10.1016/j.jagp.2023.06.001. Epub 2023 Jun 11. Am J Geriatr Psychiatry. 2023. PMID: 37365110 Free PMC article. Review.

4

An investigation of the potential clinical utility of critical slowing down as an early warning sign for recurrence of depression.

Tonge NA, Miller JP, Kharasch ED, Lenze EJ, Rodebaugh TL. Tonge NA, et al. Among authors: lenze ej. J Behav Ther Exp Psychiatry. 2024 Mar;82:101922. doi: 10.1016/j.jbtep.2023.101922. Epub 2023 Oct 27. J Behav Ther Exp Psychiatry. 2024. PMID: 37956479

5

Optimizing treatment for older adults with depression.

Srifuengfung M, Pennington BRT, Lenze EJ. Srifuengfung M, et al. Among authors: lenze ej. Ther Adv Psychopharmacol. 2023 Nov 18;13:20451253231212327. doi: 10.1177/20451253231212327. eCollection 2023. Ther Adv Psychopharmacol. 2023. PMID: 38022834 Free PMC article. Review.

6

Mindfulness Training and Exercise and Cognitive Function in Older Adults-Reply.

Lenze EJ, Twamley EW, Wetherell JL. Lenze EJ, et al. JAMA. 2023 Apr 4;329(13):1120-1121. doi: 10.1001/jama.2023.1454. JAMA. 2023. PMID: 37014341 No abstract available.

7

Digital and precision clinical trials: innovations for testing mental health medications, devices, and psychosocial treatments.

Lenze E, Torous J, Arean P. Lenze E, et al. Neuropsychopharmacology. 2024 Jan;49(1):205-214. doi: 10.1038/s41386-023-01664-7. Epub 2023 Aug 7. Neuropsychopharmacology. 2024. PMID: 37550438 Review.

8

Innovative Technologies in CNS Trials: Promises and Pitfalls for Recruitment, Retention, and Representativeness.

Lutz J, Pratap A, Lenze EJ, Bestha D, Lipschitz JM, Karantzoulis S, Vaidyanathan U, Robin J, Horan W, Brannan S, Mittoux A, Davis MC, Lakhan SE, Keefe R. Lutz J, et al. Among authors: lenze ej. Innov Clin Neurosci. 2023 Sep 1;20(7-9):40-46. eCollection 2023 Jul-Sep. Innov Clin Neurosci. 2023. PMID: 37817816 Free PMC article.

9

Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression. Reply.

Lenze EJ; OPTIMUM Study Group. Lenze EJ, et al. N Engl J Med. 2023 May 25;388(21):2013. doi: 10.1056/NEJMc2304804. N Engl J Med. 2023. PMID: 37224209 No abstract available.

10

Better Biomarkers, Faster Drugs, Stronger Models: Progress Towards Precision Psychiatry.

Siegel JS, Pearson C, Lenze EJ. Siegel JS, et al. Among authors: lenze ej. Mo Med. 2023 Jul-Aug;120(4):292-298. Mo Med. 2023. PMID: 37609458 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page